3 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Indication: Reduce risk ... Drug Class: Selective ... Dosing: 250 mcg tablet ... to reduce the risk ... won’t have any clinical
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
metabolic equivalent able ... ASA class If ... event, follow ACC algorithm ... Change in clinical ... Stable patients
Cold Urticaria
Prevalence - 0.05% in the population
Disease onset - Mostly 2nd to 4th decades of life
Causes
decades of life Causes ... and clinical associations ... Disease trigger - Direct ... #rheumatology #comparison ... #table